The role of albendazole in programmes to eliminate lymphatic filariasis.
Identifieur interne : 000160 ( Ncbi/Merge ); précédent : 000159; suivant : 000161The role of albendazole in programmes to eliminate lymphatic filariasis.
Auteurs : E A Ottesen [Suisse] ; M M Ismail ; J. HortonSource :
- Parasitology today (Personal ed.) [ 0169-4758 ] ; 1999.
Descripteurs français
- KwdFr :
- Albendazole (administration et posologie), Albendazole (usage thérapeutique), Animaux, Brugia malayi (), Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Filaricides (administration et posologie), Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Humains, Ivermectine (administration et posologie), Ivermectine (usage thérapeutique), Microfilaria (), Mâle, Observance thérapeutique, Santé publique, Wuchereria bancrofti ().
- MESH :
- administration et posologie : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- Animaux, Brugia malayi, Filariose lymphatique, Humains, Microfilaria, Mâle, Observance thérapeutique, Santé publique, Wuchereria bancrofti.
English descriptors
- KwdEn :
- Albendazole (administration & dosage), Albendazole (therapeutic use), Animals, Brugia malayi (drug effects), Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (prevention & control), Filaricides (administration & dosage), Filaricides (therapeutic use), Humans, Ivermectin (administration & dosage), Ivermectin (therapeutic use), Male, Microfilariae (drug effects), Patient Compliance, Public Health, Wuchereria bancrofti (drug effects).
- MESH :
- chemical , administration & dosage : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- drug effects : Brugia malayi, Microfilariae, Wuchereria bancrofti.
- drug therapy : Elephantiasis, Filarial.
- prevention & control : Elephantiasis, Filarial.
- Animals, Humans, Male, Patient Compliance, Public Health.
Abstract
Citing earlier advances in the treatment of lymphatic filariasis [particularly the effectiveness of single-dose diethylcarbamazine (DEC) in reducing microfilaraemia and its enhanced effectiveness when co-administered with single-dose ivermectin], Eric Ottesen, Mahroof Ismail and John Horton consider recent studies on the antifilarial activity of albendazole that have led to the current recommendations for its use in single-dose regimens in conjunction with either DEC or ivermectin for large-scale control/elimination programmes. Furthermore, the potential of albendazole as a macrofilaricide for treating individual patients with lymphatic filarial infections is emphasized as one of a number of important research questions that remain to be explored.
PubMed: 10461168
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004C17
- to stream PubMed, to step Curation: 004C17
- to stream PubMed, to step Checkpoint: 004C17
Links to Exploration step
pubmed:10461168Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of albendazole in programmes to eliminate lymphatic filariasis.</title><author><name sortKey="Ottesen, E A" sort="Ottesen, E A" uniqKey="Ottesen E" first="E A" last="Ottesen">E A Ottesen</name><affiliation wicri:level="1"><nlm:affiliation>Communicable Diseases Eradication and Elimination Department, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. ottensene@who.int</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Communicable Diseases Eradication and Elimination Department, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27</wicri:regionArea><wicri:noRegion>CH-1211 Geneva 27</wicri:noRegion></affiliation></author><author><name sortKey="Ismail, M M" sort="Ismail, M M" uniqKey="Ismail M" first="M M" last="Ismail">M M Ismail</name></author><author><name sortKey="Horton, J" sort="Horton, J" uniqKey="Horton J" first="J" last="Horton">J. Horton</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1999">1999</date><idno type="RBID">pubmed:10461168</idno><idno type="pmid">10461168</idno><idno type="wicri:Area/PubMed/Corpus">004C17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004C17</idno><idno type="wicri:Area/PubMed/Curation">004C17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004C17</idno><idno type="wicri:Area/PubMed/Checkpoint">004C17</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004C17</idno><idno type="wicri:Area/Ncbi/Merge">000160</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The role of albendazole in programmes to eliminate lymphatic filariasis.</title><author><name sortKey="Ottesen, E A" sort="Ottesen, E A" uniqKey="Ottesen E" first="E A" last="Ottesen">E A Ottesen</name><affiliation wicri:level="1"><nlm:affiliation>Communicable Diseases Eradication and Elimination Department, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. ottensene@who.int</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Communicable Diseases Eradication and Elimination Department, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27</wicri:regionArea><wicri:noRegion>CH-1211 Geneva 27</wicri:noRegion></affiliation></author><author><name sortKey="Ismail, M M" sort="Ismail, M M" uniqKey="Ismail M" first="M M" last="Ismail">M M Ismail</name></author><author><name sortKey="Horton, J" sort="Horton, J" uniqKey="Horton J" first="J" last="Horton">J. Horton</name></author></analytic><series><title level="j">Parasitology today (Personal ed.)</title><idno type="ISSN">0169-4758</idno><imprint><date when="1999" type="published">1999</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term><term>Albendazole (therapeutic use)</term><term>Animals</term><term>Brugia malayi (drug effects)</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Filaricides (administration & dosage)</term><term>Filaricides (therapeutic use)</term><term>Humans</term><term>Ivermectin (administration & dosage)</term><term>Ivermectin (therapeutic use)</term><term>Male</term><term>Microfilariae (drug effects)</term><term>Patient Compliance</term><term>Public Health</term><term>Wuchereria bancrofti (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (administration et posologie)</term><term>Albendazole (usage thérapeutique)</term><term>Animaux</term><term>Brugia malayi ()</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Filaricides (administration et posologie)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Ivermectine (administration et posologie)</term><term>Ivermectine (usage thérapeutique)</term><term>Microfilaria ()</term><term>Mâle</term><term>Observance thérapeutique</term><term>Santé publique</term><term>Wuchereria bancrofti ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brugia malayi</term><term>Microfilariae</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Male</term><term>Patient Compliance</term><term>Public Health</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Brugia malayi</term><term>Filariose lymphatique</term><term>Humains</term><term>Microfilaria</term><term>Mâle</term><term>Observance thérapeutique</term><term>Santé publique</term><term>Wuchereria bancrofti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Citing earlier advances in the treatment of lymphatic filariasis [particularly the effectiveness of single-dose diethylcarbamazine (DEC) in reducing microfilaraemia and its enhanced effectiveness when co-administered with single-dose ivermectin], Eric Ottesen, Mahroof Ismail and John Horton consider recent studies on the antifilarial activity of albendazole that have led to the current recommendations for its use in single-dose regimens in conjunction with either DEC or ivermectin for large-scale control/elimination programmes. Furthermore, the potential of albendazole as a macrofilaricide for treating individual patients with lymphatic filarial infections is emphasized as one of a number of important research questions that remain to be explored.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10461168</PMID><DateCreated><Year>1999</Year><Month>12</Month><Day>15</Day></DateCreated><DateCompleted><Year>1999</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0169-4758</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>1999</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Parasitology today (Personal ed.)</Title><ISOAbbreviation>Parasitol. Today (Regul. Ed.)</ISOAbbreviation></Journal><ArticleTitle>The role of albendazole in programmes to eliminate lymphatic filariasis.</ArticleTitle><Pagination><MedlinePgn>382-6</MedlinePgn></Pagination><Abstract><AbstractText>Citing earlier advances in the treatment of lymphatic filariasis [particularly the effectiveness of single-dose diethylcarbamazine (DEC) in reducing microfilaraemia and its enhanced effectiveness when co-administered with single-dose ivermectin], Eric Ottesen, Mahroof Ismail and John Horton consider recent studies on the antifilarial activity of albendazole that have led to the current recommendations for its use in single-dose regimens in conjunction with either DEC or ivermectin for large-scale control/elimination programmes. Furthermore, the potential of albendazole as a macrofilaricide for treating individual patients with lymphatic filarial infections is emphasized as one of a number of important research questions that remain to be explored.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ottesen</LastName><ForeName>E A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Communicable Diseases Eradication and Elimination Department, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. ottensene@who.int</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismail</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Parasitol Today</MedlineTA><NlmUniqueID>8605563</NlmUniqueID><ISSNLinking>0169-4758</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017178" MajorTopicYN="N">Brugia malayi</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008842" MajorTopicYN="N">Microfilariae</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>39</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>8</Month><Day>26</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>8</Month><Day>26</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10461168</ArticleId><ArticleId IdType="pii">S0169-4758(99)01486-6</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Suisse</li></country></list><tree><noCountry><name sortKey="Horton, J" sort="Horton, J" uniqKey="Horton J" first="J" last="Horton">J. Horton</name><name sortKey="Ismail, M M" sort="Ismail, M M" uniqKey="Ismail M" first="M M" last="Ismail">M M Ismail</name></noCountry><country name="Suisse"><noRegion><name sortKey="Ottesen, E A" sort="Ottesen, E A" uniqKey="Ottesen E" first="E A" last="Ottesen">E A Ottesen</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000160 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000160 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:10461168
|texte= The role of albendazole in programmes to eliminate lymphatic filariasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:10461168" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |